Skip to content
DataLookout
Menu

Genovn Therapeutics (Suzhou) Co., Ltd. clinical trial pipeline

Get alerts when Genovn Therapeutics (Suzhou) Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor: IL-15 Enhanced NK Cell Therapy for Solid Tumors Start date changed from estimate of Oct 8, 2026 to Nov 18, 2026 Genovn Therapeutics (Suzhou) Co., Ltd.Early Phase 1 NCT07621471
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Early Phase 1
1
Get alerts when Genovn Therapeutics (Suzhou) Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free